MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. MedImmune is pioneering innovative research and exploring novel pathways across Oncology, Respiratory, Cardiovascular & Metabolic Diseases, and Infection and Vaccines. MedImmune is headquartered in Gaithersburg, Md., one of AstraZeneca’s three global R&D centers, with additional sites in Cambridge, UK and Mountain View, Calif.

MedImmune’s SYNAGIS therapeutic is an FDA-approved prescription injection of antibodies that is given monthly to help protect high-risk infants from severe respiratory syncytial virus, or RSV.

RSV is a common virus that, like the flu, is seasonal and easily spread. Most children will get RSV by the age of two. RSV begins with cold-like symptoms but can spread to the lungs. For babies with certain health conditions, RSV can be very serious.

SYNAGIS is the first monoclonal antibody approved for the prevention of an infectious disease, as well as the first such drug to be safely used in children.

DataStream Content Solutions provides advanced content management systems to information businesses, publishers and governments to help them work at their maximum efficiency. DataStream builds databases for data conversion, editorial enhancements, XML mark-up, data storage, data revival, data delivery and complete data management. DSCS is the home of the revolutionary Legislative Impact® and Regulatory Impact® products and is a leader in the intelligent mark-up of data.

Hughes Network Systems LLC (HUGHES) is a global leader in broadband satellite technology and services for home and office. Its flagship high-speed satellite Internet service is HughesNet®, the world’s largest satellite network, with over 1 million residential and business customers across North America and Brazil.

For large enterprises and governments, the company’s HughesON® managed network services provide complete connectivity solutions, employing an optimized mix of satellite and terrestrial technologies. The company’s JUPITER™ System is the world’s most widely deployed High-Throughput Satellite (HTS) platform, operating on more than 20 satellites by leading service providers, delivering a wide range of broadband enterprise, mobility and cellular backhaul applications.

To date, Hughes has shipped more than 5.5 million terminals to customers in over 100 countries, representing an approximately 50 percent market share, and its technology is powering broadband services to aircraft around the world.

With annual revenues of over $1 billion, Hughes’ headquarters are in Germantown, Md., although the company has offices in 11 countries and customers in over 100 countries.

Potomac Photonics, a leader in microfabrication, has an extensive history of helping its clients develop miniature products and bring them to market quickly and costeffectively. Utilizing a broad range of technologies, Potomac can micromachine materials such as polymers, metals, ceramics, and glass with feature sizes that cannot be achieved using conventional processes.

Automated Precision Inc. (API) is a world leader in coordinate measurement solutions. Leading the metrology industry through innovation, API products are used by many of the world’s top automotive, aerospace, machine tool, and CMM manufacturers.

API’s technology improves production processes, from design and innovation to production, quality checks and inspections. The company offers dimensional inspection and metrology services, including consulting, calibration, machine tool error mapping, contract measurement, 3D CAD modeling and reverse engineering to solve difficult measurement problems.

20/20 GeneSystems was founded to develop and promote an innovative proteomics product line that provides drug companies, biodefense specialists and life scientists with new tools for protein analysis. The company’s first product, and the focus of the company’s work through MIPS, called BioCheck®, is the “gold standard” test for the screening of unknown suspicious powders by emergency personnel and first responders.  Since developing BioCheck, the company has expanded its scope to developing and commercializing innovative, proprietary diagnostic tests that aid in the fight against cancer. These tests generally fall into three categories: personalized medicine, early detection of lung cancer, and biological detection.

Blue Wave develops low-cost, reliable and customized thin film fabrication tools for the R&D market, enabling researchers to make advances in nanotechnology and thin-film research.

Blue Wave specializes in: manufacturing deposition systems and processing tools for semiconductor R&D; thin film coating and device fabrication; and providing quality thin film development services to clients such as the DoD and other large corporations.